Announced
Financials
Tags
Taiwan
Pending
healthcare services
Cross Border
De-SPAC
Majority
Private
Friendly
Single Bidder
Health Care Services
Acquisition
Reverse Takeover
Synopsis
Docter, a Taiwanese non-invasive blood glucose watch developer, agreed to go public via SPAC merger with Aimfinity Investment, a Cayman Islands incorporated special purpose acquisition company, in a $60m deal. “Docter Inc. is committed to pushing the boundaries of what wearable devices can achieve in the realm of health and well-being. Our team is confident that, with the support of Aimfinity Investment. I, we can continue to innovate and bring our revolutionary wearable technologies to a broader audience as a publicly traded company. We are thrilled to have found such outstanding partners as we embark on this new phase of our journey,” Hsin-Ming Huang, Docter CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.